Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 21/1/2020
SIETES contiene 92882 citas

 
 
 1 a 20 de 272 siguiente >>
Presentar resultados
Seleccionar todas
1.Enlace a cita original Cita con resumen
Anónimo. Towards better patient care: drugs to avoid in 2019. Prescrire Int 2019;39:abril. [Ref.ID 103075]
3. Cita con resumen
Herr M, Sirven N, Grondin H, Pichetti S, Sermet C. Frailty, polypharmacy, and potentially inappropriate medications in old people: findings in a representative sample of the French population. Eur J Clin Pharmacol 2017;73:1165-72. [Ref.ID 102024]
4. Cita con resumen
Jhang KM, Huang J-Y, Nfor ON, Tung Y-C, Ku W-Y, Lee C-T, Liaw Y-P. Extrapyramidal symptoms after exposure to calcium channel blocker-flunarizine or cinnarizine. Eur J Clin Pharmacol 2017;73:911-6. [Ref.ID 101996]
5. Cita con resumen
Lin H-L, Lin H-C, Tseng Y-F, Chen SC, Hsu C-Y. Risk of parkinsonism induced by flunarizine or cinnarizine: a population-based study. Eur J Clin Pharmacol 2017;73:365-71. [Ref.ID 101941]
6. Cita con resumen
Anónimo. Valvulopathies d'origine médicamenteuse. Prescrire 2013;33:668-72. [Ref.ID 96188]
7. Cita con resumen
Anónimo. Pour mieux soigner: des médicaments à écarter. Prescrire 2013;33:138-42. [Ref.ID 94882]
8. Cita con resumen
Zafonte RD, Bagiella E, Ansel BM, Novack TA, Friedewald WT, Hesdorffer DC, Timmons SD, Jallo J, Eisenberg H, Hart T, Ricker JH, Diaz-Arrastia R, Merchant RE, Temkin NR, Melton S, Dikmen SS. Effect of citicoline on functional and cognitive status among patients with traumatic brain injury: Citicoline Brain Injury Treatment Trial (COBRIT). JAMA 2012;308:1993-2000. [Ref.ID 94102]
9. Cita con resumen
Bucolo C, Longo L, Camillieri G, Drago F, Salomone S. Safety profile assessment of buflomedil: an overview of adverse reactions between 1975 and 2011. Pharmacoepidemiol Drug Saf 2012;21:1190-6. [Ref.ID 93990]
10.Tiene citas relacionadas Cita con resumen
Dávalos A, Alvarez-Sabín J, Castillo J, Díez-Tejedor E, Ferro J, Martínez-Vila E, Serena J, Segura T, Cruz VT, Masjuan J, Cobo E, Secades JJ, for the International Citicoline Trial on acUte Stroke (ICTUS) trial investigators. Citicoline in the treatment of acute ischaemic stroke: an international, randomised, multicentre, placebo-controlled study (ICTUS trial). Lancet 2012;380:349-57. [Ref.ID 93513]
11.Tiene citas relacionadas
Hankey GJ. How effective is citicoline for acute ischaemic stroke?. Lancet 2012;380:318-9. [Ref.ID 93510]
12. Cita con resumen
Anónimo. Dérivés de l'ergot de seigle: fibroses et valvulopathies. Prescrire 2012;32:361. [Ref.ID 92813]
13. Cita con resumen
Anónimo. Prises de poids d'origine médicamenteuse. Prescrire 2011;31:748-52. [Ref.ID 91601]
14. Cita con resumen
Anónimo. Buflomedil-containing medicines. WHO Pharmaceuticals Newsletter 2011;3:5. [Ref.ID 90978]
15. Cita con resumen
Anónimo. Buflomédil: encore trop d'accidents cardiaques et neurologiques mortels. Prescrire 2011;31:21. [Ref.ID 89991]
16. Cita con resumen
Anónimo. Pusillanimité. Prescrire 2011;31:5. [Ref.ID 89984]
18.
Phillips JS, Prinsley PR. Prescribing practices for betahistine. Br J Clin Pharmacol 2008;65:470-1. [Ref.ID 82502]
19. Cita con resumen
Anónimo. Acúfenos y medicamentos. Boletín Terapéutico Andaluz 2007;23:5-8. [Ref.ID 80134]
20. Cita con resumen
Anónimo. Buflomedil. Higher dose tablets withdrawn due to risk of suicide. WHO Pharmaceuticals Newsletter 2007;1:1. [Ref.ID 79562]
Seleccionar todas
 
 1 a 20 de 272 siguiente >>